Our research on ophthalmology transactions in 2020 showed that roughly half of seller groups were represented by an investment banker or M&A advisor. Of those unrepresented, most were small one- and two-physician groups. Approximately 70% of groups with five or more physicians used a sell side advisor.
Members of the FOCUS Healthcare Team were one of the most active sell-side investment banking groups in the United States overall, working on five different ophthalmology transactions.

Eric Yetter
FOCUS Managing Director and Healthcare Team Leader
Direct: 615-477-4741
